BRIEF published on 07/30/2026 at 22:10, 12 days 11 hours ago Abivax receives positive feedback from the FDA for obefazimod FDA Abivax Obefazimod Ulcerative Colitis Marketing Authorization
BRIEF published on 07/30/2026 at 22:10, 12 days 11 hours ago Abivax obtient des avancées auprès de la FDA concernant l'obefazimod pour le traitement de la colite ulcéreuse Abivax Obefazimod Rectocolite Hémorragique Soumission D'un Accord De Confidentialité Interaction Avec La FDA
BRIEF published on 07/30/2026 at 22:10, 12 days 11 hours ago Abivax reçoit un retour positif de la FDA pour l'obéfazimod FDA Abivax Obefazimod Rectocolite Hémorragique Autorisation De Mise Sur Le Marché
BRIEF published on 07/30/2026 at 22:10, 12 days 11 hours ago Abivax Advances with FDA on Obefazimod for Ulcerative Colitis Abivax Obefazimod Ulcerative Colitis NDA Submission FDA Interaction
PRESS RELEASE published on 07/30/2026 at 22:05, 12 days 11 hours ago Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod. La société se prépare à déposer sa première NDA d'ici fin 2026 FDA Abivax Obefazimod Rectocolite Hémorragique NDA
PRESS RELEASE published on 07/30/2026 at 22:05, 12 days 11 hours ago Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod Abivax announces positive pre-NDA interaction with FDA for Obefazimod, on track for NDA submission by end of 2026, reinforcing potential in treating ulcerative colitis FDA Abivax Obefazimod Ulcerative Colitis NDA Submission
BRIEF published on 07/24/2026 at 09:51, 18 days 23 hours ago Franchissement de seuil par Sofinnova Partners dans ABIVAX Euronext Paris Droits De Vote Franchissement De Seuil Abivax Sofinnova Partners
BRIEF published on 07/24/2026 at 09:51, 18 days 23 hours ago Sofinnova Partners crosses threshold in ABIVAX Euronext Paris Voting Rights Abivax Threshold Crossing Sofinnova Partners
PRESS RELEASE published on 07/24/2026 at 09:46, 18 days 23 hours ago Franchissement de seuil Déclaration de franchissement de seuil par Sofinnova Partners pour le compte du fonds Sofinnova Crossover I SLP concernant ABIVAX sur Euronext Paris Euronext Paris Déclaration Franchissement De Seuil Abivax Sofinnova Partners
BRIEF published on 07/23/2026 at 22:10, 19 days 11 hours ago Abivax is strengthening its sales team to prepare for the market launch of obefazimod Abivax Obefazimod Marketing Inflammatory Diseases Strategic Appointments
Published on 08/12/2026 at 09:01, 39 minutes ago Apex Drills 4.48% REO Over 8.0 m and 5.27% REO Over 10.2 m Within Multiple ~ 150 m Intervals of > 2.00 % REO at the Rift Rare Earth Project in SE Nebraska
Published on 08/12/2026 at 08:02, 1 hour 38 minutes ago Southern Energy Corp. Announces Spudding of Cotton Valley Test Well at Williamsburg and Appointment of Market Maker
Published on 08/12/2026 at 08:00, 1 hour 40 minutes ago Galantas Selects Engineering and Mine Planning Contractors for Andacollo Gold Project
Published on 08/12/2026 at 00:00, 9 hours 40 minutes ago Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 10 hours ago RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/12/2026 at 09:05, 35 minutes ago BASF Agricultural Solutions invests in new Climate Center at its headquarters to strengthen research capabilities
Published on 08/12/2026 at 09:05, 35 minutes ago Partnership between Novem and GPAINNOVA for the implementation of DLyte® technology
Published on 08/12/2026 at 09:00, 40 minutes ago Original-Research: Multitude AG (von NuWays AG): BUY
Published on 08/11/2026 at 17:45, 15 hours 55 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 16 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 1 day 15 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 1 day 15 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
